XML 25 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders Equity - Additional Information (Detail) (USD $)
9 Months Ended 0 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 0 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended 0 Months Ended
Sep. 30, 2013
Sep. 30, 2014
Dec. 31, 2013
Aug. 15, 2013
SAR [Member]
Sep. 30, 2014
SAR [Member]
Sep. 30, 2014
Restricted Stock [Member]
Sep. 30, 2014
Restricted Stock [Member]
Jul. 16, 2013
Underwritten Public Offering [Member]
Sep. 30, 2014
Private Placement Warrants [Member]
Sep. 30, 2013
Private Placement Warrants [Member]
Sep. 30, 2014
Private Placement Warrants [Member]
Sep. 30, 2013
Private Placement Warrants [Member]
Dec. 31, 2013
Private Placement Warrants [Member]
Sep. 30, 2014
Private Placement [Member]
Dec. 31, 2013
Private Placement [Member]
Feb. 14, 2014
Shelf Registration [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Series A convertible preferred stock, shares authorized   114,000 114,000                          
Series A convertible preferred stock, par value   $ 0.001 $ 0.001                          
Series A convertible preferred stock, shares issued   0 0                          
Series A convertible preferred stock, shares outstanding   0 0                          
Common stock exercise price   $ 0.001 $ 0.001           $ 13.00   $ 13.00          
Common stock, shares authorized   50,000,000 50,000,000                          
Common stock, shares issued   11,559,803 11,352,812                          
Common stock, shares outstanding   10,728,878 10,521,887                          
Public offering shares               2,005,000                
Underwritten public offering Price per share               $ 35.00           $ 69.00 $ 75.10  
Shares sold through Public offering               1,050,000                
Share sold by stockholders through public offering               955,000                
Proceeds to the company from Public offering $ 36,750,000             $ 34,530,000                
Public offering expense               514,000                
Grantee exercised Stock appreciation right       181,291 120,000                      
Common stock issued       96,504 85,903 656 11,503                  
Income tax benefit realized in connection with exercise of stock appreciation right         2,248,000   221,000                  
Shares vested and unexercised         61,291                      
Shares issued withheld to satisfy income tax obligation, Value           21,000 361,000                  
Shares of common stock issuable upon exercise of the private placement warrant                     750,002          
Warrants expiry date                           Apr. 29, 2016    
Shares issued for warrants exercised                 0 88,167 109,585 297,334        
Common stock reserved for the exercise of the Private Placement Warrants                 287,257   287,257   396,842      
Aggregate offering value                               $ 150,000,000